Evolent Health [EVH] vs Ge Healthcare [GEHC] Detailed Stock Comparison

Evolent Health Inc.

NYSE
Loading...

Ge Healthcare Technologies Inc.

NASDAQ
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Evolent Health Inc. wins in 4 metrics, Ge Healthcare Technologies Inc. wins in 14 metrics, with 1 ties. Ge Healthcare Technologies Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Evolent Health Inc. Ge Healthcare Technologies Inc. Better
P/E Ratio (TTM) -0.58 15.92 Ge Healthcare Technologies Inc.
Price-to-Book Ratio 0.85 3.18 Evolent Health Inc.
Debt-to-Equity Ratio 238.37 98.72 Ge Healthcare Technologies Inc.
PEG Ratio 0.00 -0.87 Tie
EV/EBITDA 13.48 10.74 Ge Healthcare Technologies Inc.
Profit Margin (TTM) -28.49% 10.10% Ge Healthcare Technologies Inc.
Operating Margin (TTM) -2.06% 15.73% Ge Healthcare Technologies Inc.
EBITDA Margin (TTM) N/A 15.73% N/A
Return on Equity -66.54% 22.38% Ge Healthcare Technologies Inc.
Return on Assets (TTM) -0.13% 5.47% Ge Healthcare Technologies Inc.
Free Cash Flow (TTM) $4.76M $1.51B Ge Healthcare Technologies Inc.
Dividend Yield N/A 0.25% N/A
1-Year Return -41.96% -9.79% Ge Healthcare Technologies Inc.
Price-to-Sales Ratio (TTM) 0.19 1.60 Evolent Health Inc.
Enterprise Value $1.19B $39.12B Ge Healthcare Technologies Inc.
EV/Revenue Ratio 0.63 1.90 Evolent Health Inc.
Gross Profit Margin (TTM) 20.75% 39.68% Ge Healthcare Technologies Inc.
Revenue per Share (TTM) $16 $45 Ge Healthcare Technologies Inc.
Earnings per Share (Diluted) $-5.07 $4.55 Ge Healthcare Technologies Inc.
Beta (Stock Volatility) 0.37 1.31 Evolent Health Inc.
Short % of Float 14.47% 3.07% Ge Healthcare Technologies Inc.

Evolent Health Inc. vs Ge Healthcare Technologies Inc. Stock Performance Analysis

Loading Price Chart...

EVH
GEHC

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Evolent Health Inc.-2.08%0.86%18.69%55.63%14.08%20.82%
Ge Healthcare Technologies Inc.-0.64%0.14%6.58%-10.27%-23.32%-21.81%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Evolent Health Inc.-41.96%-83.22%-75.66%-70.50%-74.55%-74.55%
Ge Healthcare Technologies Inc.-9.79%-17.13%14.87%14.87%14.87%14.87%

Performance & Financial Health Analysis: Evolent Health Inc. vs Ge Healthcare Technologies Inc.

MetricEVHGEHC
Market Information
Market Cap i$329.33M$31.89B
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i2,779,2872,502,586
90 Day Avg. Volume i2,982,7063,405,145
Last Close$4.70$64.76
52 Week Range$2.10 - $12.06$58.75 - $89.77
% from 52W High-61.04%-27.86%
All-Time High$39.78 (Sep 12, 2022)$94.80 (Feb 10, 2025)
% from All-Time High-88.19%-31.69%
Growth Metrics
Quarterly Revenue Growth-0.28%0.07%
Quarterly Earnings GrowthN/A-0.18%
Financial Health
Profit Margin (TTM) i-0.28%0.10%
Operating Margin (TTM) i-0.02%0.16%
Return on Equity (TTM) i-0.67%0.22%
Debt to Equity (MRQ) i238.3798.72
Cash & Liquidity
Book Value per Share (MRQ)$3.72$22.77
Cash per Share (MRQ)$1.36$9.86
Operating Cash Flow (TTM) i$38.84M$1.99B
Levered Free Cash Flow (TTM) i$98.41M$1.69B
Dividends
Last 12-Month Dividend Yield iN/A0.25%
Last 12-Month Dividend iN/A$0.20

Valuation & Enterprise Metrics Analysis: Evolent Health Inc. vs Ge Healthcare Technologies Inc.

MetricEVH (Apr 24, 2026)GEHC (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i-0.5815.92
Forward P/E i7.1313.02
PEG Ratio i0.00-0.87
Price to Sales (TTM) i0.191.60
Price to Book (MRQ) i0.853.18
Market Capitalization
Market Capitalization i$329.33M$31.89B
Enterprise Value i$1.19B$39.12B
Enterprise Value Metrics
Enterprise to Revenue i0.631.90
Enterprise to EBITDA i13.4810.74
Risk & Other Metrics
Beta i0.371.31
Book Value per Share (MRQ) i$3.72$22.77

Financial Statements Comparison: Evolent Health Inc. vs Ge Healthcare Technologies Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricEVH (2025)GEHC (2025)
Revenue/Sales i1.88B20.63B
Cost of Goods Sold i1.48B12.38B
COGS % of Revenue i78.7%60.0%
Gross Profit i399.88M8.25B
Gross Margin i21.3%40.0%
Research & Development iN/A1.26B
Operating Income (EBIT) i-19.83M2.76B
Operating Margin i-1.1%13.4%
EBITDA i85.02M3.69B
EBITDA Margin i4.5%17.9%
Pre-Tax Income i-534.64M2.77B
Pre-Tax Income % of Revenue i-28.5%13.4%
Income Tax i-126,000614.00M
Income Tax % of Revenue i0.0%3.0%
Net Income (Profit) i-534.51M2.15B
Profit Margin i-28.5%10.4%

Balance Sheet & Liquidity Metrics

MetricEVH (2025)GEHC (2025)
Cash & Equivalents i151.86M4.49B
Total Current Assets i506.37M12.50B
Total Current Assets % of Revenue i27.0%60.6%
Total Current Liabilities i385.26M9.11B
Total Current Liabilities % of Revenue i20.5%44.1%
Long-Term Debt i974.36M9.82B
Long-Term Debt % of Revenue i51.9%47.6%
Total Shareholders Equity i415.19M10.60B
Retained Earnings i-1.32B5.28B
Retained Earnings % of Revenue i-70.1%25.6%
Property, Plant & Equipment i4.37M410.00M

Cash Flow Statement Comparison

MetricEVH (2025)GEHC (2025)
Operating Cash Flow i-425.17M3.02B
Operating Cash Flow % of Revenue i-22.7%14.6%
Capital Expenditures iN/A-482.00M
Free Cash Flow i4.76M1.51B
FCF Margin i0.3%7.3%
Debt Repayment i-342.98M-1.77B
Common Stock Repurchase i-40.00M-200.00M

Short Interest & Institutional Ownership Analysis

MetricEVHGEHC
Shares Short i15.95M12.36M
Short Ratio i5.143.20
Short % of Float i14.47%3.07%
Shares Outstanding i111.63M455.74M
Float Shares i92.79M454.48M
% Held by Insiders i1.62%0.35%
% Held by Institutions i110.52%93.39%
% Held by Public i-12.14%6.26%

Dividend Analysis & Yield Comparison: Evolent Health Inc. vs Ge Healthcare Technologies Inc.

MetricEVHGEHC
Last 12-Month Dividend iN/A$0.20
Last 12-Month Dividend Yield iN/A0.25%
3-Year Avg Annual Dividend iN/A$0.15
3-Year Avg Dividend Yield iN/A0.04%
3-Year Total Dividends iN/A$0.45
Ex-Dividend DateN/AApr 02, 2026